Insider Trading Alert - REX, PSEC And NUVA Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 3, 2014, 85 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $4,255.74 to $5,989,983.27.

Highlighted Stocks Traded by Insiders:

REX American Resources (REX) - FREE Research Report

Rose Stuart A, who is Cob; Ceo at REX American Resources, sold 18,000 shares at $107.31 on Sept. 3, 2014. Following this transaction, the Cob; Ceo owned 668,758 shares meaning that the stake was reduced by 2.62% with the 18,000-share transaction.

The shares most recently traded at $108.76, up $1.45, or 1.33% since the insider transaction. Historical insider transactions for REX American Resources go as follows:

  • 4-Week # shares sold: 88,000
  • 12-Week # shares sold: 456,146
  • 24-Week # shares sold: 886,726

The average volume for REX American Resources has been 174,400 shares per day over the past 30 days. REX American Resources has a market cap of $871.2 million and is part of the conglomerates sector and conglomerates industry. Shares are up 139.14% year-to-date as of the close of trading on Wednesday.

REX American Resources Corporation, through its subsidiaries, produces and sells ethanol. The company operates in two segments, Alternative Energy and Real Estate. The company has a P/E ratio of 12.7. Currently, there is 1 analyst who rates REX American Resources a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on REX - FREE

TheStreet Quant Ratings rates REX American Resources as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full REX American Resources Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Prospect Capital Corporation (PSEC) - FREE Research Report

Eliasek M Grier, who is Chief Operating Officer at Prospect Capital Corporation, bought 20,000 shares at $10.26 on Sept. 3, 2014. Following this transaction, the Chief Operating Officer owned 187,196 shares meaning that the stake was boosted by 11.96% with the 20,000-share transaction.

The shares most recently traded at $10.36, up $0.10, or 0.97% since the insider transaction. Historical insider transactions for Prospect Capital Corporation go as follows:

  • 4-Week # shares bought: 31,300
  • 12-Week # shares bought: 286,300
  • 24-Week # shares bought: 386,300

The average volume for Prospect Capital Corporation has been 4.9 million shares per day over the past 30 days. Prospect Capital Corporation has a market cap of $3.5 billion and is part of the financial sector and financial services industry. Shares are down 8.02% year-to-date as of the close of trading on Wednesday.

Prospect Capital Corporation is a business development company. The stock currently has a dividend yield of 12.87%. The company has a P/E ratio of 9.7. Currently, there are 6 analysts who rate Prospect Capital Corporation a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PSEC - FREE

TheStreet Quant Ratings rates Prospect Capital Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, expanding profit margins, impressive record of earnings per share growth and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Prospect Capital Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

NuVasive (NUVA) - FREE Research Report

Valentine Keith, who is President & COO at NuVasive, sold 2,500 shares at $35.14 on Sept. 3, 2014. Following this transaction, the President & COO owned 77,285 shares meaning that the stake was reduced by 3.13% with the 2,500-share transaction.

The shares most recently traded at $35.61, up $0.47, or 1.32% since the insider transaction. Historical insider transactions for NuVasive go as follows:

  • 4-Week # shares sold: 6,510
  • 12-Week # shares sold: 63,742
  • 24-Week # shares sold: 79,338

The average volume for NuVasive has been 356,300 shares per day over the past 30 days. NuVasive has a market cap of $1.7 billion and is part of the health care sector and health services industry. Shares are up 9.84% year-to-date as of the close of trading on Wednesday.

NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. Currently, there are 8 analysts who rate NuVasive a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NUVA - FREE

TheStreet Quant Ratings rates NuVasive as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full NuVasive Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Oil Slips From Three-Year Peak After Trump Tweets Anger at OPEC

Oil Slips From Three-Year Peak After Trump Tweets Anger at OPEC

Swiss Franc Slides to Three-Year Low as U.S. Sanctions on Russian Oligarchs Bite

Swiss Franc Slides to Three-Year Low as U.S. Sanctions on Russian Oligarchs Bite

GE Beats Earnings Estimates and 4 Other Stories You Must Know Friday Morning

GE Beats Earnings Estimates and 4 Other Stories You Must Know Friday Morning

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

General Electric, Honeywell, Wells Fargo and Qualcomm - 5 Things You Must Know

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip